| Literature DB >> 24480614 |
Wei-Ping Chen1, Yan Xiong1, Yong-Xiang Shi1, Peng-Fei Hu1, Jia-Peng Bao1, Li-Dong Wu2.
Abstract
Astaxanthin is a red carotenoid pigment which exerts multiple biological activities. However, little is known about the effects of astaxanthin on matrix metalloproteinases (MMPs) in OA. The present study investigated the effects of astaxanthin on MMPs in human chondrocytes. Human chondrocytes were pretreated with astaxanthin at 1, 10 or 50μM, then, cells were stimulated with IL-1β (10ng/ml) for 24h. MMP-1, MMP-3 and MMP-13 were observed. We found that astaxanthin reduced the expression of MMP-1, MMP-3 and MMP-13 as well as the phosphorylation of two mitogen-activated protein kinases (MAPK) (p38 and ERK1/2) in IL-1β-stimulated chondrocytes. Astaxanthin also blocked the IκB-α degradation. These results suggest that astaxanthin may be beneficial in the treatment of OA.Entities:
Keywords: Astaxanthin; Matrix metalloproteinase; Osteoarthritis
Mesh:
Substances:
Year: 2014 PMID: 24480614 DOI: 10.1016/j.intimp.2013.12.007
Source DB: PubMed Journal: Int Immunopharmacol ISSN: 1567-5769 Impact factor: 4.932